Melek Altunbas-Yorgun
Ihlas Marmara Evleri - I. Kisim, 34899, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Are Management Strategies Associated with Tolerance Acquisition in Infants with Cow's Milk-Induced Allergic Proctocolitis?
Journal: Journal of clinical medicine
Published: April 03, 2026
Genomic diagnosis and multisystem phenotyping in pediatric congenital analbuminemia: clinical, coagulation, and immune signatures.
Journal: Frontiers in pediatrics
Published: February 13, 2026
A Comprehensive Assessment of Health-Related Quality of Life in Hereditary Angioedema as a Patient-Centered Approach.
Journal: International archives of allergy and immunology
Published: November 28, 2025
Medical Algorithm: Personalized Immunoglobulin Replacement Therapy for Inborn Errors of Immunity.
Journal: Allergy
Published: November 22, 2025
A homozygous CTLA-4 variant causes CTLA-4 deficiency with severe immune dysregulation.
Journal: Journal of human immunity
Published: October 20, 2025
Triggers, clinical spectra and outcomes of pediatric anaphylaxis in a tertiary center: impact of comorbidities and cofactors on severity.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: October 11, 2025
SPINK5 Variants Drive Clinical Variability in Netherton Syndrome Through Th2/Th17 Skewing and Influence Therapeutic Outcomes.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 01, 2025
Multidimensional Assessment of Patient-Reported-Outcomes in a Multicenter Cohort of Inborn Errors of Immunity.
Journal: Journal of clinical immunology
Published: April 16, 2025
An evaluation of pozelimab for the treatment of CHAPLE disease.
Journal: Expert opinion on biological therapy
Published: December 10, 2024
Clinical and Immunological Prognostic Factors With Novel Variants in a Large Cohort of Diacylglycerol Acyltransferase 1 Deficiency.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 28, 2024
Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease.
Journal: The Journal of allergy and clinical immunology
Published: September 22, 2024
Pharmacotherapy for CD55 deficiency with CHAPLE disease: how close are we to a cure?
Journal: Expert opinion on pharmacotherapy
Published: August 02, 2024
Last Updated: 09/26/2026